Ampio pharmaceuticals to present poster at the international society for aerosols in medicine (isam) 23rd international congress

Englewood, colo., may 21, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the company's poster presentation, "regulatory decisions during covid-19: efficient nonclinical inhalation toxicology for a clinical program," being given at the 23rd international congress of the international society for aerosols in medicine (isam), in boise, idaho, may 22 to 26, 2021.
AMPE Ratings Summary
AMPE Quant Ranking